DUX4 and facioscapulohumeral muscular dystrophy: Misexpression of DUX4 and its target genes in muscles of FSHD patients leads to muscle toxicity and degeneration, resulting in clinical disease (DeSimone et al., 2017; Lemmers et al., 2010).